<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73900">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01951443</url>
  </required_header>
  <id_info>
    <org_study_id>KRAB</org_study_id>
    <nct_id>NCT01951443</nct_id>
  </id_info>
  <brief_title>Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure</brief_title>
  <acronym>KRAB</acronym>
  <official_title>Acute Effect of Rg3-enriched Korean Red Ginseng (Steamed Panax Ginseng C.A. Meyer) Standardized Extract on Arterial Stiffness and Aortic and Brachial Blood Pressure in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the acute effect of a standardized extract of KRG
      (Rg3-KRG) consisting of 30% total ginsenosides, including 10% Rg3 ginsenoside on arterial
      stiffness and blood pressure, as measured by the following parameters: aortic augmentation
      index, peripheral blood pressure, central blood pressure
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>To evaluate the acute effect of Rg3-KRG on arterial stiffness in healthy adult volunteers, as measured by aortic augmentation index (AIx).</measure>
    <time_frame>Two weeks (measurements taken on two separate  visits with minimum one week washout)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the acute effect of Rg3-KRG on aortic and brachial blood pressure in healthy adult volunteers.</measure>
    <time_frame>Two weeks (measurements taken on two separate visits with minimum one week washout)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>To evaluate the acute safety of Rg3-KRG in healthy adult volunteers using a 48hr symptoms questionnaire.</measure>
    <time_frame>Two weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Arterial Stiffness, Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Ginseng</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Encapsulated 400mg Rg3-KRG extract</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wheat Bran</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>400mg Wheat Bran capsule</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ginseng</intervention_name>
    <description>400mg of encapsulated Rg3-KRG</description>
    <arm_group_label>Ginseng</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wheat Bran</intervention_name>
    <description>400mg of encapsulated wheat bran</description>
    <arm_group_label>Wheat Bran</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Age 18-70 years

          -  BMI &lt; 30 kg/m2

          -  Brachial systolic blood pressure &lt; 140 mmHg

          -  Brachial diastolic blood pressure &lt; 90 mmHg

        Main Exclusion Criteria:

          -  BMI &gt;30kg/m2

          -  Hypertensive (brachial systolic BP ≥140mmHg and/or diastolic BP ≥90mmHg)

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Vladimir Vuksan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Risk Factor Modification Centre - St. Michael's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Amir Hanna (Qualified investigator), MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Risk Factor Modification Centre, St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>April 25, 2014</lastchanged_date>
  <firstreceived_date>August 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ginseng</keyword>
  <keyword>clinical trial</keyword>
  <keyword>vascular</keyword>
  <keyword>ginsenosides</keyword>
  <keyword>blood pressure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
